However, further study is needed to determine if EphA2 activity is affected by miR-26b in other cancers with high EphA2 expression, like breast cancer, colon cancer, and prostate cancer; and whether miR-26b-EphA2 dysregulation represents a new mechanism for cellular transformation. The gene discussed is EPHA2; the disease is breast carcinoma.